Hepatitis B Archives - Infectious Disease Advisor

Hepatitis B Risk Not Substantially Elevated With Celiac Disease

By

Emily Pond

April 18, 2022

Researchers sought to determine whether patients with celiac disease are at increased risk for HBV infection despite having received HBV vaccination.

Hepatitis

PreHevbrio Now Available for Adult Hepatitis B Vaccination

By

Brian Park, PharmD

April 1, 2022

The approval was based on data from two phase 3 studies, which compared the safety and immunogenicity of PreHevbrio to Engerix-B in adults.

Hepatitis

High Immunogenicity Observed Among Healthy Adults After 3 Doses of the 3-Antigen Formulation Hepatitis B Vaccine

By

Jessica Nye, PhD

January 11, 2022

Investigators assessed the manufacturing consistency, safety, and efficacy of a 3-antigen hepatitis B vaccine vs a single-antigen formulation.

Hepatitis

Hepatitis B Shots Advised for All US Adults Younger Than 60 Years

November 10, 2021

Until now, the shots were recommended only for certain groups of adults

Hepatitis

Phase 1 Trial Data Support Safety, Efficacy of Novel Hepatitis B Treatment

By

Emily Pond

September 15, 2021

Investigators assessed the safety profile and antiviral activity of the agent RO7049389 for the treatment of chronic hepatitis B virus infection.

Hepatitis

HBV Suppression Lowers Liver Cancer Rates in Patients Coinfected With HIV

By

Kristin Della Volpe

July 9, 2021

Findings emphasize the importance of strategies to help HBV-HIV coinfected patients maximize antiretroviral adherence to achieve hepatitis B viral suppression.

COVID19

HBV Infection Not Linked to Liver Injury, Mortality in COVID-19

By

Kristin Della Volpe

May 18, 2021

Patients with current or past HBV infection are not at greater risk for liver injury or mortality during COVID-19 infection.

Hepatitis

Besifovir Dipivoxil Maleate Effective, Safe for Long-Term Treatment of Chronic Hepatitis B

By

Emily Pond

June 11, 2020

Study data supports the long-term efficacy and safety of besifovir dipivoxil maleate (BSV) for the treatment of chronic hepatitis B (CHB).

Hepatitis

USPSTF Recommends Hep B Screening for Those at Increased Risk

May 13, 2020

The U.S. Preventive Services Task Force (USPSTF) recommends screening adolescents and adults at increased risk for hepatitis B virus (HBV) infection.

Hepatitis B is a serious disease that attacks the liver. Approximately 95% of new HB infections occur among adults and unvaccinated adults which behavior risk behaviors. Encourage all patients to get vaccinated for Hepatitis B.

Hepatitis Advisor

Hepatitis B Exposure Risk, Prevalence in the US Adult Homeless Population

By

Bradley van Paridon

March 23, 2020

Hepatitis B virus prevalence was 7 to 10 times higher in a homeless population of Los Angeles compared to the general population of the United States.